[go: up one dir, main page]

IN2015DN03169A - - Google Patents

Info

Publication number
IN2015DN03169A
IN2015DN03169A IN3169DEN2015A IN2015DN03169A IN 2015DN03169 A IN2015DN03169 A IN 2015DN03169A IN 3169DEN2015 A IN3169DEN2015 A IN 3169DEN2015A IN 2015DN03169 A IN2015DN03169 A IN 2015DN03169A
Authority
IN
India
Prior art keywords
extract
formulations
vaccinia virus
greater uniformity
rabbit skin
Prior art date
Application number
Other languages
English (en)
Inventor
Yoshitaka Nakazawa
Yoji Shibayama
Ko Nakamura
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2012225133A external-priority patent/JP5275502B1/ja
Priority claimed from JP2013092006A external-priority patent/JP5438234B1/ja
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Publication of IN2015DN03169A publication Critical patent/IN2015DN03169A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
IN3169DEN2015 2012-10-10 2013-10-09 IN2015DN03169A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012225133A JP5275502B1 (ja) 2012-10-10 2012-10-10 抽出物及び製剤
JP2013092006A JP5438234B1 (ja) 2013-04-25 2013-04-25 抽出物及び該抽出物を含有する製剤
PCT/JP2013/077534 WO2014057995A1 (ja) 2012-10-10 2013-10-09 抽出物及び該抽出物を含有する製剤

Publications (1)

Publication Number Publication Date
IN2015DN03169A true IN2015DN03169A (es) 2015-10-02

Family

ID=49359802

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3169DEN2015 IN2015DN03169A (es) 2012-10-10 2013-10-09

Country Status (9)

Country Link
US (2) US20150265655A1 (es)
EP (1) EP2910249B1 (es)
KR (1) KR102131025B1 (es)
CN (4) CN103357006B (es)
AU (1) AU2013327849B2 (es)
CA (1) CA2887117C (es)
IN (1) IN2015DN03169A (es)
TW (1) TWI594757B (es)
WO (1) WO2014057995A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014178394A1 (ja) * 2013-04-30 2014-11-06 日本臓器製薬株式会社 抽出物及び該抽出物を含有する製剤
TWI705816B (zh) * 2016-01-29 2020-10-01 國立大學法人千葉大學 用以製造肌損傷之預防或治療劑或修復促進劑之牛痘病毒接種炎症組織萃取物之用途
CN109504649B (zh) * 2017-09-15 2022-06-14 天津小西生物医药科技有限公司 使用兔皮提取物促进细胞增殖的方法
CN109512838B (zh) * 2017-09-15 2022-05-10 天津小西生物医药科技有限公司 一种兔皮提取物及其制备方法和用途
JP2019142802A (ja) * 2018-02-20 2019-08-29 学校法人東海大学 ワクシニアウイルス接種炎症組織抽出物を含有するn‐アセチルガラクトサミン転移酵素発現促進剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176193A (ja) 1984-09-21 1986-04-18 工業技術院長 加工布の縁部連続折込み装置
JPS61142268A (ja) 1984-12-17 1986-06-30 松下電器産業株式会社 電気錠解錠装置
JP2594222B2 (ja) 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−kf
CN1055249C (zh) 1998-07-15 2000-08-09 沈继平 一种镇痛药和其制造方法
CN1207005C (zh) 2002-10-31 2005-06-22 威世药业(如皋)有限公司 含生物活性物质的兔皮和其用途
CA2503810C (en) * 2002-10-31 2012-03-13 Kusuki Nishioka Therapeutic agent for fibromyalgia
JP3818657B2 (ja) 2004-12-01 2006-09-06 日本臓器製薬株式会社 乾燥物及びその製造方法
CN1613305B (zh) 2004-12-06 2011-01-12 威世药业(如皋)有限公司 一种从含新型活性物质的兔皮中提取的活性制剂
CN100542543C (zh) 2005-06-17 2009-09-23 日本脏器制药株式会社 干燥物及其制造法
JP4005115B1 (ja) * 2007-02-08 2007-11-07 日本臓器製薬株式会社 疼痛疾患治療剤
TWI483729B (zh) * 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及/或排尿障礙之改善或治療劑
TWI504894B (zh) 2010-06-25 2015-10-21 Nippon Zoki Pharmaceutical Co 被檢物質的判定或評價方法
WO2014178394A1 (ja) 2013-04-30 2014-11-06 日本臓器製薬株式会社 抽出物及び該抽出物を含有する製剤

Also Published As

Publication number Publication date
CN106109498A (zh) 2016-11-16
CA2887117C (en) 2021-03-09
CN106074607A (zh) 2016-11-09
EP2910249A1 (en) 2015-08-26
EP2910249B1 (en) 2019-12-04
CN103357006A (zh) 2013-10-23
US20150265655A1 (en) 2015-09-24
TW201438724A (zh) 2014-10-16
CN104703613B (zh) 2016-08-17
US20190151370A1 (en) 2019-05-23
CA2887117A1 (en) 2014-04-17
KR20150064036A (ko) 2015-06-10
CN106109498B (zh) 2020-06-02
KR102131025B1 (ko) 2020-07-07
WO2014057995A1 (ja) 2014-04-17
AU2013327849B2 (en) 2017-12-07
CN104703613A (zh) 2015-06-10
US11529374B2 (en) 2022-12-20
HK1211496A1 (en) 2016-05-27
EP2910249A4 (en) 2016-07-27
CN103357006B (zh) 2014-10-15
TWI594757B (zh) 2017-08-11
AU2013327849A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
MX2013010170A (es) Moduladores heterociclicos de sintesis lipidica.
EA202190619A1 (ru) Противовирусные соединения
EA201590868A1 (ru) Противовирусные соединения
MX2016017355A (es) Lipido que comprende acido docosapentaenoico.
EP3674320A3 (en) Production of heterodimeric proteins
EA201790963A1 (ru) Противовирусные соединения
HK1206779A1 (en) Modified polynucleotides for the production of nuclear proteins
CO6511271A2 (es) Compuestos de imidazopiridinil-aminopiridina sustituida
MX2019006379A (es) Induccion de gen de trail de molecula pequeña en celulas normales y tumorales como una terapia anticancer.
IN2015DN03029A (es)
EP2900069B8 (en) Differentiation of human ips cells to human alveolar type ii via definitive endoderm
MX2020008031A (es) Composiciones y metodos para reducir el contenido de alcohol en sangre.
ECSP14013327A (es) Compuestos con actividad nematicida
IN2014DN06104A (es)
EA201491537A1 (ru) Повышение засухоустойчивости у растений: upl3
IN2014MN01331A (es)
MX2022002057A (es) Variantes de enzima con propiedades de ester sintasa mejoradas.
BR112012016894A2 (pt) lactobacilos com ação antioxidante.
IN2015DN03169A (es)
AU338093S (en) Street light
MX2019011805A (es) Plantas de melon con resistencia al virus asociado al amarilleamiento del melon (myav).
BR112015002464B8 (pt) processo para a preparação de carbamat-benzoxazinona, carbamat-benzoxazinona e uso da carbamat-benzoxazinona
MX2020001357A (es) Produccion microbiana de aminas grasas.
IN2014MN01469A (es)
EA201590564A1 (ru) Стабильные составы